Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
36 studies found for:    Open Studies | "Goiter"
Show Display Options
Rank Status Study
21 Recruiting Teprotumumab Treatment in Patients With Active Thyroid Eye Disease
Conditions: Thyroid Associated Ophthalmopathies;   Thyroid-Associated Ophthalmopathy
Interventions: Drug: teprotumumab;   Drug: Placebo
22 Recruiting Selenium in Mild Thyroid Eye Disease in North America
Condition: Thyroid Associated Ophthalmopathies
Interventions: Dietary Supplement: Sodium selenite;   Dietary Supplement: Sugar pill
23 Recruiting Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Hyaluronic Acid Gel injection;   Drug: Saline injection
24 Recruiting Early Levothyroxine Post Radioactive Iodine
Condition: Graves' Disease
Intervention: Drug: Levothyroxine
25 Recruiting Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism
Condition: Graves' Hyperthyroidism
Interventions: Dietary Supplement: Selenium;   Other: Placebo
26 Not yet recruiting B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Rituximab;   Drug: Placebo
27 Recruiting Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy
Condition: Thyroid Associated Opthalmopathies
Interventions: Drug: Prednisone+placebo of Doxycycline;   Drug: Doxycycline+placebo of Prednisone
28 Not yet recruiting Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Condition: Graves Disease
Intervention:
29 Recruiting Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
Conditions: Thyroid Associated Ophthalmopathies;   Graves´ Ophthalmopathy;   Thyroid Eye Disease
Interventions: Drug: Tocilizumab (RoActemra®);   Drug: Sterile 0.9% Sodium Chloride
30 Recruiting Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy
Condition: Graves Ophthalmopathy
Interventions: Procedure: blepharotomy;   Procedure: posterior approach
31 Unknown  The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy
Condition: Graves' Ophthalmopathy
Intervention:
32 Not yet recruiting Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Radiation: External beam radiotherapy;   Drug: intravenous corticosteroids (methylprednisolone)
33 Recruiting Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People
Condition: Graves' Ophthalmopathy
Intervention:
34 Recruiting The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
Conditions: Thyroid-associated Ophthalmopathy;   Dry Eye Syndrome
Interventions: Drug: Methylprednisolone;   Drug: Esomeprazole
35 Unknown  Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction
Condition: Graves Ophthalmopathy
Interventions: Drug: Botulinum Toxin Type A;   Drug: Saline injection
36 Unknown  Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
Condition: Graves' Disease
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years